Concurrent Changes in Serum Butyrylcholinesterase and Prescribed Phosphate-Lowering Medication Intensity in Maintenance Hemodialysis: An Exploratory Longitudinal Study

Background Prescribed phosphate-lowering therapy reflects both laboratory results and clinical decisions in maintenance hemodialysis. Whether changes in a study-specific prescription intensity score accompany changes in serum butyrylcholinesterase (BChE) is unknown. We explored this association without assuming that the score measures dietary intake. Methods This retrospective longitudinal study included 110 adults receiving thrice-weekly hemodialysis for 16 months. The primary analysis evaluated the contemporaneous association between 3-month changes in post-laboratory P-index and BChE using interval fixed effects and patient-clustered robust standard errors. Albumin was the comparator, and a lagged model examined whether prior P-index predicted next-quarter BChE. Results A 6-point P-index increase was associated with a 2.04% contemporaneous BChE increase after adjustment for normalized protein catabolic rate (nPCR), phosphorus, inflammation, volume status, dialysis dose, and mineral-bone variables (95% confidence interval [CI] 0.65–3.46%; P = 0.004). The corresponding albumin association was 0.41% (95% CI -0.53 to 1.36%; P = 0.393), and the association was stronger for BChE than albumin (difference 1.63 percentage points; 95% CI 0.51–2.76; P for interaction = 0.005). Prior P-index did not clearly predict next-quarter BChE (0.35%; 95% CI -0.02 to 0.72%; P = 0.067). Conclusions Changes in BChE and prescribed phosphate-lowering intensity were associated over the same interval, whereas the lagged association was inconclusive. The score is unvalidated and the findings do not establish temporal direction, dietary intake, medication effects, or clinical utility.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11534801/v1
Primary Topic
Parathyroid Disorders and Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Concurrent Changes in Serum Butyrylcholinesterase and Prescribed Phosphate-Lowering Medication Intensity in Maintenance Hemodialysis: An Exploratory Longitudinal Study

Ryo Kamimatsuse, Hirosuke Nakata
1 links
Research Square
Parathyroid Disorders and Treatments
preprint

Concurrent Changes in Serum Butyrylcholinesterase and Prescribed Phosphate-Lowering Medication Intensity in Maintenance Hemodialysis: An Exploratory Longitudinal Study

Ryo Kamimatsuse, Hirosuke Nakata
preprint en

Abstract

Background Prescribed phosphate-lowering therapy reflects both laboratory results and clinical decisions in maintenance hemodialysis. Whether changes in a study-specific prescription intensity score accompany changes in serum butyrylcholinesterase (BChE) is unknown. We explored this association without assuming that the score measures dietary intake. Methods This retrospective longitudinal study included 110 adults receiving thrice-weekly hemodialysis for 16 months. The primary analysis evaluated the contemporaneous association between 3-month changes in post-laboratory P-index and BChE using interval fixed effects and patient-clustered robust standard errors. Albumin was the comparator, and a lagged model examined whether prior P-index predicted next-quarter BChE. Results A 6-point P-index increase was associated with a 2.04% contemporaneous BChE increase after adjustment for normalized protein catabolic rate (nPCR), phosphorus, inflammation, volume status, dialysis dose, and mineral-bone variables (95% confidence interval [CI] 0.65–3.46%; P = 0.004). The corresponding albumin association was 0.41% (95% CI -0.53 to 1.36%; P = 0.393), and the association was stronger for BChE than albumin (difference 1.63 percentage points; 95% CI 0.51–2.76; P for interaction = 0.005). Prior P-index did not clearly predict next-quarter BChE (0.35%; 95% CI -0.02 to 0.72%; P = 0.067). Conclusions Changes in BChE and prescribed phosphate-lowering intensity were associated over the same interval, whereas the lagged association was inconclusive. The score is unvalidated and the findings do not establish temporal direction, dietary intake, medication effects, or clinical utility.

Research Square
Uji-Tokushukai Medical Center (JP)
Good health and well-being
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon